Concourse Financial Group Securities’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 777 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2821 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2820 |
|
|
2024
Q2 | – | Sell |
-1,300
| Closed | -$6.6K | – | 2863 |
|
|
2024
Q1 | $6.6K | Hold |
1,300
| – | – | ﹤0.01% | 1830 |
|
|
2023
Q4 | $7.79K | Hold |
1,300
| – | – | ﹤0.01% | 1746 |
|
|
2023
Q3 | $9.2K | Sell |
1,300
-1
| -0.1% | -$7 | ﹤0.01% | 1668 |
|
|
2023
Q2 | $9.16K | Hold |
1,301
| – | – | ﹤0.01% | 1671 |
|
|
2023
Q1 | $10.9K | Buy |
1,301
+1
| +0.1% | +$8 | ﹤0.01% | 1646 |
|
|
2022
Q4 | $14.9K | Hold |
1,300
| – | – | ﹤0.01% | 1548 |
|
|
2022
Q3 | $16K | Hold |
1,300
| – | – | ﹤0.01% | 1356 |
|
|
2022
Q2 | $14K | Hold |
1,300
| – | – | ﹤0.01% | 1549 |
|
|
2022
Q1 | $21K | Buy |
1,300
+500
| +63% | +$8.08K | ﹤0.01% | 1461 |
|
|
2021
Q4 | $11K | Hold |
800
| – | – | ﹤0.01% | 1827 |
|
|
2021
Q3 | $11K | Hold |
800
| – | – | ﹤0.01% | 1850 |
|
|
2021
Q2 | $13K | Hold |
800
| – | – | ﹤0.01% | 1771 |
|
|
2021
Q1 | $8K | Hold |
800
| – | – | ﹤0.01% | 1808 |
|
|
2020
Q4 | $6K | Hold |
800
| – | – | ﹤0.01% | 1826 |
|
|
2020
Q3 | $3K | Buy |
+800
| New | +$3K | ﹤0.01% | 1914 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2418 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2491 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2425 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2126 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2536 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2543 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2410 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1942 |
|